← All companies

IAM

Iambic Therapeutics, Inc.

IAM Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$14.67

-1.13 -7.15%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$14.10 – $25.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Regulation FD disclosure Oct 16, 2026

Other filings

4 PRIMARY DOCUMENT Oct 19, 2026

424B4 Oct 15, 2026

S-8 Oct 15, 2026

3 PRIMARY DOCUMENT Oct 14, 2026

EFFECT Oct 14, 2026

CERT Oct 14, 2026

8-A12B Oct 13, 2026

S-1/A Oct 8, 2026

S-1 Sep 21, 2026

D Item 06b Sep 9, 2026

DRS/A Aug 28, 2026

DRS Jul 24, 2026